Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR012232)
Formula Reactant X-396 Product X-396 M577c/M577
Reactant Info Product Info
Metabolic Type Oxidation - Mono-oxidation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012246 X-396 X-396 M346 Hydrolysis - Hydrolysis X-396 [1]
MR012240 X-396 X-396 M371 Oxidation - O-dealkylation X-396 [1]
MR012238 X-396 X-396 M465 Hydrolysis - Hydrolysis X-396 [1]
MR012244 X-396 X-396 M521 Oxidation - N,N-depropylation X-396 [1]
MR012243 X-396 X-396 M577a/b Oxidation - Mono-oxidation X-396 [1]
MR012242 X-396 X-396 M577d Unclear - Unclear X-396 [1]
MR012245 X-396 X-396 M737 Hydrolysis - Hydrolysis X-396 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR012233 X-396 M577c/M577 X-396 M575 Unclear - Unclear X-396 [1]
MR012235 X-396 M577c/M577 X-396 M593a/b Unclear - Unclear X-396 [1]
MR012237 X-396 M577c/M577 X-396 M753 Unclear - Unclear X-396 [1]
References
1 Mass balance, metabolic disposition, and pharmacokinetics of [(14)C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.